CIPLANSECipla Limited· PharmaceuticalsHighNegative
Announced Thu, 26 Mar · 20:38 IST

Mr Pradeep Bhadauria, Global Chief Scientific Officer has resigned to pursue interests outside Cipla and his last working day will be 31st March, 2026.

Kmp ResignedManagement Changes View source PDF

CIPLA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.1%1-day move
₹1248.40
prior close
₹1226.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.4+1.0+0.7+0.9-2.1-3.9-4.3-3.6-3.6-1.9-0.7+5.3+13.9+16.1
Up moveDown movePending
AI summary

Cipla Limited has informed stock exchanges that Mr Pradeep Bhadauria, Global Chief Scientific Officer and a member of the company's Management Council, has resigned from his role. He is an employee of Cipla USA Inc., a wholly owned subsidiary of Cipla. His last working day will be 31st March 2026, and he is stepping down to pursue interests outside Cipla. The company has not announced a replacement in this filing.

Likely market impact

This is the exit of a senior scientific leader, which could raise short-term questions about continuity in Cipla's R&D pipeline. However, since he is leaving to pursue outside interests (and not due to any cited governance issue) and the company is providing a transition period, the immediate impact on shareholders is likely limited. Investors should watch for the announcement of a successor.